The first voluntary product recall in California was initiated by the vape cartridge manufacturer, The Bloom Brand, on July 25 and the second by Lowell Herb Co. concerning a batch of their pre-rolled cannabis cigarettes.
The extraction processes provide highly-efficient methods to obtain cannabinoids and other desired compounds from the cannabis plant at a greater purity than conventional methods.
Californian cannabis users could be put at serious risk from fungal and bacterial contaminants as new regulations lack effective safety screenings, despite the state’s Quality Control Committee specifically advocating for such tests.
As tighter regulations mandate more rigorous testing, cannabis labs in California must plan and adapt to keep up with the huge influx of samples.
What's most transformative about this drug approval is that this is the first time the FDA - the governmental arbiter of safe and effective medicine in the United States - has approved any substance derived from the cannabis plant.
Mice who received a combination of CBD and chemotherapy survived nearly three times as long as the mice given the placebo, and around twice as long as the mice given CBD or chemotherapy alone.
Across four distinct strains it was observed that the flower samples taken from the upper third of the plant had a higher THC content than those at the base of the plant, and in two of the strains tested the difference was equivalent to the upper flowers being around twice as potent as the lower flowers.
Massachusetts law requires that all recreational marijuana products bear a seal showing they have been tested by a Commission-licensed independent laboratory for contaminants and potency levels.